Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2017

May 11, 2017

31982_dirs_2017-05-11_fe576364-f516-4dd4-a4ac-588e37772604.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2017-05-11

Reporting Person: PHILLIPS BARCLAY A (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-05-11 Common Stock P 25000 $0.838 Acquired 36612 Direct